Legal Status:
In Canada, kratom occupies a legal gray area. It is not listed under the Controlled Drugs and Substances Act (CDSA), meaning it is not technically classified as a prohibited substance. However, Health Canada has taken the position that kratom is not approved for human consumption as a supplement or medicine. Health Canada classifies kratom as an “unauthorized natural health product”, making its sale for human consumption illegal without official authorization.
Law Enforcement:
Although there is no explicit ban under the CDSA, Health Canada actively monitors and seizes kratom products marketed for human consumption, especially if they claim health benefits without official approval. In some cases, personal importation of kratom may also be seized by the Canada Border Services Agency (CBSA) if deemed to violate health regulations.
Research and Medical Use:
There is no official authorization for the use of kratom as a medicine or health supplement in Canada. Kratom products sold must comply with the Food and Drugs Act regulations, but to date, no kratom products have been issued a Natural Product Number (NPN) required for legal sale as a natural health product.
Kratom Usage in Canada
- General Usage:
Despite its unapproved status for consumption, kratom remains available on the black market or through online sales, often marketed as “not for human consumption” (e.g., as a research chemical or for aromatherapy) to circumvent regulations. Users in Canada typically utilize kratom to alleviate chronic pain, manage anxiety, boost energy, or as an alternative to reduce opioid dependence, although these claims are not supported by official clinical trials. - Community and Advocacy:
There is a community of kratom users and advocates in Canada pushing for legalization or clearer regulations, arguing that kratom has potential medical benefits, such as pain relief or treatment for opioid addiction. However, Health Canada remains cautious due to the lack of strong scientific evidence regarding its safety and effectiveness. - Health Risks:
Health Canada warns about the side effects of kratom, including nausea, vomiting, constipation, dependence, respiratory issues, and the risk of liver damage at high doses. Reports from the United Nations Office on Drugs and Crime (UNODC) and global studies also highlight the potential for addiction and dangerous interactions with other substances, which underpin Canada’s conservative stance.
Latest News and Information
- Health Canada Policy:
As of May 2025, Health Canada has not changed its stance on kratom. Warnings about health risks continue to be issued, and enforcement actions against unauthorized kratom sales persist. For instance, stores or online sites marketing kratom as a health supplement risk product seizures or fines. - Comparison with Medical Cannabis:
Canada has legalized cannabis for medical use since 2001 under the Marihuana for Medical Purposes Regulations regulated by Health Canada. However, no similar steps have been taken for kratom, indicating a stricter approach to this plant compared to cannabis, despite both having histories of traditional use and similar controversies. - Global Discussions:
Canada is influenced by international discussions on kratom, particularly following the United Nations Commission on Narcotic Drugs meeting in March 2025, where several European countries and U.S. states advocated for banning kratom due to its potential for misuse. If the World Health Organization (WHO) classifies kratom as a psychotropic substance, Canada is likely to tighten regulations further. - Export Market from Indonesia:
Indonesia, as one of the main exporters of kratom, began regulating kratom exports in February 2025, with export values reaching US$1.053 million for 351 tons, primarily to the U.S. and Europe. However, Canada is not a primary market due to Health Canada’s strict regulations limiting the import of kratom products for consumption.
Discussion and Implications
- Why Is Canada Cautious?
Health Canada’s stance on kratom is based on the lack of clinical evidence supporting its safety and effectiveness, as well as reports of serious side effects like dependence and liver toxicity. Unlike medical cannabis, which has undergone clinical trials and strict regulations, kratom lacks sufficient data to be considered safe by Canadian health authorities. - Impact on Users:
The prohibition of sales for human consumption pushes users to the black market, increasing the risk of low-quality or contaminated products (e.g., with heavy metals or bacteria like salmonella). This is a major concern, as unregulated products can exacerbate health risks. - Future Prospects:
There is no indication of regulatory changes in Canada in the near future. However, pressure from the user community and potential new research (e.g., from Indonesia’s National Research and Innovation Agency, which indicates kratom’s analgesic benefits) may influence future discussions. Canada may await WHO recommendations before taking further steps.
Conclusion
In Canada, kratom remains unauthorized for human consumption under Health Canada regulations, although it is not explicitly banned under the Controlled Drugs and Substances Act. Law enforcement focuses on seizing products marketed for consumption, and kratom use is limited to the black market or risky personal imports. There have been no significant policy changes as of May 2025, and Canada’s conservative stance is influenced by concerns over side effects and the lack of scientific evidence. Unlike medical cannabis, which has been legalized, kratom is still far from achieving similar status in Canada.
